首页> 外文期刊>有機合成化学協会誌 >Research and Process Development of Cefditoren Pivoxil: an Oral Cephalosporin Antibiotic
【24h】

Research and Process Development of Cefditoren Pivoxil: an Oral Cephalosporin Antibiotic

机译:头孢托仑酯:口服头孢菌素抗生素的研究与工艺开发

获取原文
获取原文并翻译 | 示例
           

摘要

Cefditoren Pivoxil was synthesized in the course of study on a series of cephalosporins having various heterocycles attached to the C3-position of the cephem nucleus through Z-and E-etheno groups. Introduction of the side chains to the cephalosporins was achieved by a Wittig reaction. The reaction showed rather poor Z-E selectivity (Z:E = 1:1 to 4:1) in the stage of screening research. Investigation was started for improvement of the Z-selectivity soon after determining Cefditoren Pivoxil as a development candidate substance, and relatively high Z-selectivity (Z:E = 94:6) was finally achieved. The overall yield of Cefditoren Pivoxil was 49.6% in the established manufacturing synthetic method. Cefditoren, the active form of Cefditoren Pivoxil, has remarkably potent activity to penicillin-resistant Streptococcus pneumoniae (PRSP) and #beta#-lactamase-negative-ampicillin resistant Haemophilus influenzae (BLNAR) among the oral #beta#-lactam antibiotics.
机译:头孢托仑匹罗西酯是在一系列头孢菌素的研究过程中合成的,这些头孢菌素具有多种杂环,它们通过Z-和E-乙炔基连接到头孢烯核的C3-位。通过维蒂希反应将侧链引入头孢菌素。在筛选研究阶段,反应显示出相当差的Z-E选择性(Z:E = 1:1至4:1)。在确定头孢托仑匹罗西林为开发候选物质后不久就开始进行Z选择性改善的研究,最终获得了相对较高的Z选择性(Z:E = 94:6)。在既定的制造合成方法中,头孢托仑匹罗西尔的总产率为49.6%。头孢托仑匹伐西尔的活性形式头孢托仑对口服#beta#-内酰胺抗生素中的青霉素耐药性肺炎链球菌(PRSP)和#beta#-内酰胺酶阴性-氨苄青霉素耐药的流感嗜血杆菌(BLNAR)具有显着的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号